Hu, Baoying <br/><br/>
Blockade of DC-SIGN  [electronic resource] 

 -  Cancer research  04 2020 
 - 1707-1719 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-19-2254  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antibodies, Neutralizing<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cell Adhesion Molecules--antagonists & inhibitors<br/>Cytokines--metabolism<br/>Disease Progression<br/>Female<br/>Humans<br/>Immunotherapy--methods<br/>Lectins, C-Type--antagonists & inhibitors<br/>Macrophage Inflammatory Proteins--metabolism<br/>Macrophages--immunology<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins--metabolism<br/>Prognosis<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Receptors, Cell Surface--antagonists & inhibitors<br/>Sequence Analysis, RNA<br/>Tumor Escape--immunology<br/>Tumor Microenvironment--immunology<br/>Urinary Bladder Neoplasms--immunology<br/>Young Adult